Jonathan B. Zuckerman

Intensive Care Medicine

100 Foden Rd Ste 103
South Portland, ME 04106

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Impact of COVID-19 and CFTR Modulators on Cystic Fibrosis: A Real-World Analysis of Care Patterns.

Impact of COVID-19 and CFTR Modulators on Cystic Fibrosis: A Real-World Analysis of Care Patterns.

Journal: Pediatric pulmonology

Published: September 17, 2025

Predictors of frequency of CF care in the US Cystic Fibrosis Foundation Patient Registry.

Predictors of frequency of CF care in the US Cystic Fibrosis Foundation Patient Registry.

Journal: PloS one

Published: August 21, 2024

C-Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations.

C-Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations.

Journal: Pediatric pulmonology

Published: February 15, 2024

Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis.

Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 08, 2024

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis.

Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: October 14, 2023

Unusual Cause of Hemoptysis in a Woman With Cystic Fibrosis.

Unusual Cause of Hemoptysis in a Woman With Cystic Fibrosis.

Journal: Chest

Published: April 13, 2023

Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry.

Gaps in Cystic Fibrosis Care Are Associated with Reduced Lung Function in the U.S. Cystic Fibrosis Foundation Patient Registry.

Journal: Annals of the American Thoracic Society

Published: April 07, 2023

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical study.

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical study.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 09, 2023

Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis Study.

Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally Inserted Venous Catheters in People With Cystic Fibrosis Study.

Journal: Chest

Published: December 29, 2022

A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends.

A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends.

Journal: Scientific reports

Published: November 07, 2020

Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.

Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.

Journal: Antimicrobial agents and chemotherapy

Published: November 05, 2020

Urinary stone disease prevalence and associations in cystic fibrosis.

Urinary stone disease prevalence and associations in cystic fibrosis.

Journal: Urolithiasis

Published: July 19, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026